A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Hologic to Host Innovative Product Experiences and Medical Education Sessions On-site and Virtually at RSNA 2021

Hologic, Inc. will showcase its extensive portfolio of breast and skeletal health products, including screening and diagnostics solutions, breast biopsy, and breast cancer treatment and monitoring solutions, at the 107th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) from Nov. 28 to Dec. 2.

On-site at McCormick Place, in the South Hall in Booth #2511, Hologic will offer attendees opportunities to engage with products, including the Dimensions® mammography portfolio, Mach™ ultrasound systems, and a full suite of breast biopsy and surgery solutions. Additionally, the Company will host a series of both CME and non-CME accredited medical education symposiums and lunch-and-learn sessions, accessible to attendees on-site and from remote locations.

“We’re excited to provide our attendees hands-on experiences with our category-leading innovations, both in our booth and during our medical sessions, as we explore the future of breast health at RSNA 2021,” said Jennifer Meade, Hologic’s Division President, Breast and Skeletal Health Solutions. “Our commitment to delivering clinically proven solutions across the continuum of care to improve outcomes, reduce costs and increase patient satisfaction remains steadfast, and we’re ready to bring that commitment to life through our comprehensive programming at this year’s meeting both in-person and virtually.”

Medical sessions and symposia taking place throughout the event include:

  • Clinical Perspective: 3D-Guided Breast Biopsies and Real-Time Specimen Imaging
    Harriet B. Borofsky, M.D.
    Sunday, Nov. 28: 11:45am – 12:45pm CT
  • Artificial Intelligence in Breast Imaging (CME)
    Sarah (Sally) Friedewald, M.D., FACR
    Monday, Nov. 29: 8:00 – 9:00am CT
  • Options and Tips in Breast Localization
    Barry Rosen, M.D., FACS; Colleen M. Madden, M.D.
    Monday, Nov. 29: 12:15 – 1:15pm CT
  • Contrast Enhanced Mammography: Implementation, Application and Biopsy (CME)
    Ryan Gabriel, M.D.
    Tuesday, Nov. 30: 8:00 – 9:00am CT
  • Advancing Clinical Excellence with ShearWave™ Elastography
    Priyanka Grover, M.D.
    Tuesday, Nov. 30: 12:15 – 1:15pm CT
  • A New Era of Breast Tomosynthesis: Using High-Resolution Imaging with 3DQuorum™ Technology
    Stamatia V. Destounis, M.D., FACR, FSBI, FAIUM
    Wednesday, Dec. 1: 12:15 – 1:15pm CT

For more information on Hologic’s RSNA 2021 offerings or to RSVP for a medical education session, please visit www.HologicVirtual.com.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy